My Quote Request
6505-01-247-9167
20 Products
NDC00469-3770-25
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012479167
NSN
6505-01-247-9167
NDC00469-3770-25
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012479167
NSN
6505-01-247-9167
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 25 VIAL
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: NONBACTERIOSTATIC
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 2
Related Searches:
NDC00014-0851-55
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505012480948
NSN
6505-01-248-0948
NDC00014-0851-55
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505012480948
NSN
6505-01-248-0948
MFG
SEARLE G D AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 2500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SCORED
Related Searches:
MELLARIL TABLETS
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012480949
NSN
6505-01-248-0949
MELLARIL TABLETS
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012480949
NSN
6505-01-248-0949
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THIOPROPAZATE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
NDC00078-0005-08
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012480949
NSN
6505-01-248-0949
NDC00078-0005-08
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012480949
NSN
6505-01-248-0949
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THIOPROPAZATE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
18100
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012480950
NSN
6505-01-248-0950
18100
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012480950
NSN
6505-01-248-0950
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC/0182-1300-01
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012480950
NSN
6505-01-248-0950
NDC/0182-1300-01
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012480950
NSN
6505-01-248-0950
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00071-0557-24
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012480950
NSN
6505-01-248-0950
NDC00071-0557-24
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505012480950
NSN
6505-01-248-0950
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS VERAPAMIL HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00003-1316-35
IOPAMIDOL INJECTION,USP
NSN, MFG P/N
6505012480951
NSN
6505-01-248-0951
NDC00003-1316-35
IOPAMIDOL INJECTION,USP
NSN, MFG P/N
6505012480951
NSN
6505-01-248-0951
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 76.000 PERCENTAGE, W/V IOPAMIDOL ACTIVE INGREDIENT
ADMINISTRATION: INTRAVASCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOPAMIDOL INJECTION 100 ML VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: CONTAINS 755MG IOPAMIDOL(APPROX 370MG ORGANICALLY BOUND IODINE)AND 1MG TROMETHAMINE PER ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00270-1316-35
IOPAMIDOL INJECTION,USP
NSN, MFG P/N
6505012480951
NSN
6505-01-248-0951
NDC00270-1316-35
IOPAMIDOL INJECTION,USP
NSN, MFG P/N
6505012480951
NSN
6505-01-248-0951
MFG
BRACCO DIAGNOSTICS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 76.000 PERCENTAGE, W/V IOPAMIDOL ACTIVE INGREDIENT
ADMINISTRATION: INTRAVASCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOPAMIDOL INJECTION 100 ML VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: CONTAINS 755MG IOPAMIDOL(APPROX 370MG ORGANICALLY BOUND IODINE)AND 1MG TROMETHAMINE PER ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
MELLARIL
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012481665
NSN
6505-01-248-1665
MELLARIL
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012481665
NSN
6505-01-248-1665
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
NDC00078-0004-08
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012481665
NSN
6505-01-248-1665
NDC00078-0004-08
THIORIDAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012481665
NSN
6505-01-248-1665
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
NDC00045-0511-72
CODEINE PHOSPHATE AND ACETAMINOPHEN TABLETS
NSN, MFG P/N
6505012484679
NSN
6505-01-248-4679
NDC00045-0511-72
CODEINE PHOSPHATE AND ACETAMINOPHEN TABLETS
NSN, MFG P/N
6505012484679
NSN
6505-01-248-4679
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS CODEINE PHOSPHATE ACTIVE INGREDIENT AND 300.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE III;WARNING AND CAUTION STATEMENTS:MAY BE HABIT FORMING
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
TYLENOL WITH CODEINE NO. 2
CODEINE PHOSPHATE AND ACETAMINOPHEN TABLETS
NSN, MFG P/N
6505012484679
NSN
6505-01-248-4679
TYLENOL WITH CODEINE NO. 2
CODEINE PHOSPHATE AND ACETAMINOPHEN TABLETS
NSN, MFG P/N
6505012484679
NSN
6505-01-248-4679
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS CODEINE PHOSPHATE ACTIVE INGREDIENT AND 300.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE III;WARNING AND CAUTION STATEMENTS:MAY BE HABIT FORMING
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
1529
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012485396
NSN
6505-01-248-5396
1529
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012485396
NSN
6505-01-248-5396
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1200.000 GRAMS BARIUM SULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1200.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: IN 2000 ML. JUG; 60% W/V AFTER MIXING
Related Searches:
NDC00224-0223-08
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012485396
NSN
6505-01-248-5396
NDC00224-0223-08
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012485396
NSN
6505-01-248-5396
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1200.000 GRAMS BARIUM SULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1200.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: IN 2000 ML. JUG; 60% W/V AFTER MIXING
Related Searches:
TONOJUG
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012485396
NSN
6505-01-248-5396
TONOJUG
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505012485396
NSN
6505-01-248-5396
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1200.000 GRAMS BARIUM SULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1200.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: IN 2000 ML. JUG; 60% W/V AFTER MIXING
Related Searches:
NDC00832-0304-00
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012485398
NSN
6505-01-248-5398
NDC00832-0304-00
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012485398
NSN
6505-01-248-5398
MFG
U S DEPT OF VETERANS AFFAIRS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CHLORPROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
THERAPEUTIC EQUIVALENT: PHARMACEUTICAL BASICS INC
Related Searches:
NDC00031-6709-78
METOCLOPRAMIDE INJECTION,USP
NSN, MFG P/N
6505012485399
NSN
6505-01-248-5399
NDC00031-6709-78
METOCLOPRAMIDE INJECTION,USP
NSN, MFG P/N
6505012485399
NSN
6505-01-248-5399
MFG
ROBINS A H CO INC GOVERNMENT SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOCLOPRAMIDE INJECTION USP 5MG/ML 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: NOTE: F
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC61703-0210-11
METOCLOPRAMIDE INJECTION,USP
NSN, MFG P/N
6505012485399
NSN
6505-01-248-5399
NDC61703-0210-11
METOCLOPRAMIDE INJECTION,USP
NSN, MFG P/N
6505012485399
NSN
6505-01-248-5399
MFG
FAULDING PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOCLOPRAMIDE INJECTION USP 5MG/ML 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: NOTE: F
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
REGLAN
METOCLOPRAMIDE INJECTION,USP
NSN, MFG P/N
6505012485399
NSN
6505-01-248-5399
MFG
ROBINS A H CO INC GOVERNMENT SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOCLOPRAMIDE INJECTION USP 5MG/ML 10ML VIAL 25S
III SUPPLEMENTARY FEATURES: NOTE: F
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25